COVID-19 Detection Kits Market Size Sees 17.3% Growth to Hit USD 8 Billion By 2026 - Global Trade Magazine
  May 28th, 2020 | Written by

COVID-19 Detection Kits Market Size Sees 17.3% Growth to Hit USD 8 Billion By 2026

[shareaholic app="share_buttons" id="13106399"]

The global COVID-19 detection kits market should increase from USD 3.3 billion till now in 2020 to USD 8 billion in 2026 at a compound annual growth rate of 17.3% for 2020-2026.

COVID-19 detection kits market is anticipated to garner noteworthy growth on account of growing cases of coronavirus registered worldwide. For the record, COVID-19 is a respiratory infection that is highly contagious and transmits through direct contact with an infected person or indirect contact with affected surfaces located near the immediate environment.

As of now, this virus has spread all over the world. Containing its spread has proven to be challenging for most developed as well as developing countries. In a bid to curb the spread of coronavirus, numerous countries are using COVID-19 detection kits that help identify the symptoms of the disease in early-stage patients.

Countries with a huge number of COVID-19 cases are currently going through grave public health problems. As a result, regulatory bodies like the U.S. FDA have decided to ease the regulatory process for COVID-19 detection kits, following the Emergency Use Authorization (EUA) guideline. This has enabled manufacturers to launch their test kits in the market more quickly.

Technological innovation and subsequent development in the field of coronavirus diagnostic kits will enhance the COVID-19 detection kits industry outlook. According to a study conducted by Global Market Insights, Inc., the COVID-19 detection kits market is estimated to reach USD 8 billion by the year 2026.

This growth can be contributed to the below-mentioned trends:

Immense popularity of RT-PCR assay kits-

Rising incidence of COVID-19 around the world could play a crucial role in driving the demand for RT-PCR assay kits. The segment is expected to be more profitable and might achieve 96% of the overall market share within 2020.

As per the Centers for Disease Control and Prevention (CDC), nearly 0.6 million positive COVID-19 cases have been reported up to this date in the U.S. Rising cases in the region may support the demand for RT-PCR assay kits. Other alternatives for RT-PCR assay kits include immunoassay test strips/cassettes.

Escalating demand across APAC-

The outbreak of COVID-19 in densely populated areas like India and China could augment the Asia Pacific COVID-19 detection kits industry over the years. Estimates claim that the regional market is likely to observe nearly 21% CAGR by 2026.

Facilities in APAC have recorded some recurrence cases of COVID-19 after the successful containment of the virus. This could develop the need for COVID-19 detection kits in the future.

Implementation of lucrative business strategies-

Companies operating in the market are implementing multiple growth strategies to expand their product portfolio and geographical presence by taking part in novel R&D initiatives.

Taking March 2020 for instance, Hologic revealed that it will be receiving grant funding from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to scale the production of COVID-19 detection kits. This collaboration would allow the firm to cater to the proliferating demand for detection kits.

Apart from Hologic, Co-Diagnostics, Cepheid, Abbott Laboratories, BGI, F. Hoffmann-La Roche, BioFire Diagnostics, Guangzhou Wondfo Biotech, GenMark Diagnostics, Qiagen, Quidel Corporation, and Mylab Discovery Solutions are some other leading firms in the COVID-19 detection kits market.

Source: Global Market Insights, Inc.